Chinese General Practice ›› 2025, Vol. 28 ›› Issue (12): 1459-1464.DOI: 10.12114/j.issn.1007-9572.2024.0118
• Original Research • Previous Articles Next Articles
Received:
2024-04-25
Revised:
2024-06-19
Published:
2025-04-20
Online:
2025-02-06
Contact:
GUO Shubin
通讯作者:
郭树彬
作者简介:
作者贡献:
李秋敬负责研究设计、数据收集、统计分析、论文撰写;商娜进行数据收集与整理、论文修订;高倩、杨黎进行数据收集、统计分析指导;郭树彬负责论文审校、质量控制,对文章整体负责。所有作者确认了论文的最终稿。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0118
项目 | 生存组(n=250) | 死亡组(n=85) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄[M(P25,P75),岁] | 76(69,84) | 82(75,88) | 3.745 | <0.001 |
性别[例(%)] | 0.010a | 0.979 | ||
男 | 121(48.4) | 41(48.2) | ||
女 | 129(51.6) | 44(51.8) | ||
BMI(kg/m2) | 23.4±3.6 | 22.0±3.8 | -3.179b | 0.002 |
基础疾病[例(%)] | ||||
高血压 | 123(49.2) | 52(61.2) | 3.647a | 0.056 |
冠状动脉粥样硬化性心脏病 | 76(30.4) | 25(29.4) | 0.029a | 0.864 |
2型糖尿病 | 94(37.6) | 29(34.1) | 0.331a | 0.565 |
恶性肿瘤 | 40(16.0) | 21(24.7) | 3.228a | 0.072 |
慢性肾脏病 | 33(13.2) | 17(20.0) | 2.310a | 0.129 |
慢性肺部疾病 | 21(8.4) | 8(9.4) | 0.082a | 0.774 |
慢性肝脏疾病 | 11(4.4) | 4(4.7) | 0.014a | 0.906 |
实验室检查指标[M(P25,P75)] | ||||
白细胞计数(×109/L) | 10.88(7.11,14.30) | 10.37(7.39,16.63) | 0.943 | 0.346 |
中性粒细胞计数(×109/L) | 8.76(5.06,12.81) | 9.19(6.25,14.77) | 1.169 | 0.243 |
血红蛋白(g/L) | 121(103,138) | 116(84,137) | -1.959 | 0.050 |
血小板计数(×109/L) | 189(137,240) | 181(119,257) | -0.561 | 0.575 |
白蛋白(g/L) | 37.3(33.3,41.5) | 33.5(29.5,39.2) | -4.283 | <0.001 |
肌酐(μmol/L) | 83.6(63.2,129.6) | 140.3(74.5,244.4) | 3.730 | <0.001 |
D-二聚体(mg/L) | 2.11(1.21,3.82) | 2.11(1.60,6.52) | 1.757 | 0.079 |
降钙素原(ng/mL) | 0.81(0.16,2.22) | 0.81(0.36,7.23) | 2.123 | 0.034 |
L3 SMI[M(P25,P75),cm2/m2] | 34.82(30.19,41.26) | 30.38(24.78,32.87) | -5.817 | <0.001 |
NRS2002评分[M(P25,P75),分] | 3(2,4) | 4(4,6) | 6.526 | <0.001 |
脓毒性休克[例(%)] | 70(28.0) | 46(54.1) | 19.115a | <0.001 |
SOFA评分[M(P25,P75),分] | 3(2,5) | 6(4,9) | 6.820 | <0.001 |
APACHE Ⅱ评分[M(P25,P75),分] | 11(6,15) | 17(11,24) | 6.688 | <0.001 |
住院时间[M(P25,P75),d] | 10(6,14) | 8(3,18) | -1.053 | 0.293 |
Table 1 Comparison of clinical characteristics between survival and non-survival group among older patients with intra-abdominal sepsis
项目 | 生存组(n=250) | 死亡组(n=85) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄[M(P25,P75),岁] | 76(69,84) | 82(75,88) | 3.745 | <0.001 |
性别[例(%)] | 0.010a | 0.979 | ||
男 | 121(48.4) | 41(48.2) | ||
女 | 129(51.6) | 44(51.8) | ||
BMI(kg/m2) | 23.4±3.6 | 22.0±3.8 | -3.179b | 0.002 |
基础疾病[例(%)] | ||||
高血压 | 123(49.2) | 52(61.2) | 3.647a | 0.056 |
冠状动脉粥样硬化性心脏病 | 76(30.4) | 25(29.4) | 0.029a | 0.864 |
2型糖尿病 | 94(37.6) | 29(34.1) | 0.331a | 0.565 |
恶性肿瘤 | 40(16.0) | 21(24.7) | 3.228a | 0.072 |
慢性肾脏病 | 33(13.2) | 17(20.0) | 2.310a | 0.129 |
慢性肺部疾病 | 21(8.4) | 8(9.4) | 0.082a | 0.774 |
慢性肝脏疾病 | 11(4.4) | 4(4.7) | 0.014a | 0.906 |
实验室检查指标[M(P25,P75)] | ||||
白细胞计数(×109/L) | 10.88(7.11,14.30) | 10.37(7.39,16.63) | 0.943 | 0.346 |
中性粒细胞计数(×109/L) | 8.76(5.06,12.81) | 9.19(6.25,14.77) | 1.169 | 0.243 |
血红蛋白(g/L) | 121(103,138) | 116(84,137) | -1.959 | 0.050 |
血小板计数(×109/L) | 189(137,240) | 181(119,257) | -0.561 | 0.575 |
白蛋白(g/L) | 37.3(33.3,41.5) | 33.5(29.5,39.2) | -4.283 | <0.001 |
肌酐(μmol/L) | 83.6(63.2,129.6) | 140.3(74.5,244.4) | 3.730 | <0.001 |
D-二聚体(mg/L) | 2.11(1.21,3.82) | 2.11(1.60,6.52) | 1.757 | 0.079 |
降钙素原(ng/mL) | 0.81(0.16,2.22) | 0.81(0.36,7.23) | 2.123 | 0.034 |
L3 SMI[M(P25,P75),cm2/m2] | 34.82(30.19,41.26) | 30.38(24.78,32.87) | -5.817 | <0.001 |
NRS2002评分[M(P25,P75),分] | 3(2,4) | 4(4,6) | 6.526 | <0.001 |
脓毒性休克[例(%)] | 70(28.0) | 46(54.1) | 19.115a | <0.001 |
SOFA评分[M(P25,P75),分] | 3(2,5) | 6(4,9) | 6.820 | <0.001 |
APACHE Ⅱ评分[M(P25,P75),分] | 11(6,15) | 17(11,24) | 6.688 | <0.001 |
住院时间[M(P25,P75),d] | 10(6,14) | 8(3,18) | -1.053 | 0.293 |
变量 | β | SE | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|---|
L3 SMI | -0.079 | 0.021 | 13.569 | 0.924 | 0.886~0.964 | <0.001 |
NRS2002评分 | 0.271 | 0.097 | 7.898 | 1.312 | 1.086~1.585 | 0.005 |
SOFA评分 | 0.157 | 0.054 | 8.516 | 1.170 | 1.053~1.300 | 0.004 |
APACHE Ⅱ评分 | 0.051 | 0.024 | 4.305 | 1.052 | 1.003~1.103 | 0.038 |
常数项 | -1.129 | 0.875 | 1.663 | 0.323 | 0.197 |
Table 2 Multivariable Logistic regression analysis of risk factors associated with in-hospital mortality among older patients with intra-abdominal sepsis
变量 | β | SE | Wald χ2值 | OR值 | 95%CI | P值 |
---|---|---|---|---|---|---|
L3 SMI | -0.079 | 0.021 | 13.569 | 0.924 | 0.886~0.964 | <0.001 |
NRS2002评分 | 0.271 | 0.097 | 7.898 | 1.312 | 1.086~1.585 | 0.005 |
SOFA评分 | 0.157 | 0.054 | 8.516 | 1.170 | 1.053~1.300 | 0.004 |
APACHE Ⅱ评分 | 0.051 | 0.024 | 4.305 | 1.052 | 1.003~1.103 | 0.038 |
常数项 | -1.129 | 0.875 | 1.663 | 0.323 | 0.197 |
Figure 2 The ROC curves of L3 SMI,SOFA score,APACHE Ⅱ score and combined variables on the risk of in-hospital mortality in older patients with intra-abdominal sepsis
变量 | AUC(95%CI) | 最佳截断值 | 约登指数 | 灵敏度 | 特异度 | P值 |
---|---|---|---|---|---|---|
L3 SMI | 0.711(0.650~0.772) | 33.30 cm2/m2 | 0.364 | 0.788 | 0.576 | <0.001 |
SOFA评分 | 0.740(0.675~0.806) | 5.5分 | 0.455 | 0.647 | 0.808 | <0.001 |
APACHE Ⅱ评分 | 0.742(0.684~0.801) | 12.5分 | 0.346 | 0.718 | 0.628 | <0.001 |
L3 SMI联合SOFA评分 | 0.795(0.742~0.847) | 0.336 | 0.468 | 0.600 | 0.868 | <0.001 |
L3 SMI联合APACHE Ⅱ评分 | 0.792(0.741~0.844) | 0.221 | 0.452 | 0.776 | 0.676 | <0.001 |
Table 3 The predictive value of L3 SMI,SOFA score,APACHEⅡ score and combined variables on the risk of in-hospital mortality in older patients with intra-abdominal sepsis
变量 | AUC(95%CI) | 最佳截断值 | 约登指数 | 灵敏度 | 特异度 | P值 |
---|---|---|---|---|---|---|
L3 SMI | 0.711(0.650~0.772) | 33.30 cm2/m2 | 0.364 | 0.788 | 0.576 | <0.001 |
SOFA评分 | 0.740(0.675~0.806) | 5.5分 | 0.455 | 0.647 | 0.808 | <0.001 |
APACHE Ⅱ评分 | 0.742(0.684~0.801) | 12.5分 | 0.346 | 0.718 | 0.628 | <0.001 |
L3 SMI联合SOFA评分 | 0.795(0.742~0.847) | 0.336 | 0.468 | 0.600 | 0.868 | <0.001 |
L3 SMI联合APACHE Ⅱ评分 | 0.792(0.741~0.844) | 0.221 | 0.452 | 0.776 | 0.676 | <0.001 |
指标 | 差异 | Z值 | P值 |
---|---|---|---|
SOFA评分比L3 SMI | 0.029 | 0.651 | 0.515 |
L3 SMI联合SOFA评分比L3 SMI | 0.084 | 3.587 | <0.001 |
L3 SMI联合SOFA评分比SOFA评分 | 0.054 | 2.114 | 0.035 |
L3 SMI联合SOFA评分比APACHE Ⅱ评分 | 0.052 | 1.577 | 0.115 |
L3 SMI联合SOFA评分比APACHE Ⅱ评分联合L3 SMI | 0.002 | 0.131 | 0.895 |
APACHE Ⅱ评分比L3 SMI | 0.031 | 0.722 | 0.470 |
APACHE Ⅱ评分比SOFA评分 | 0.002 | 0.058 | 0.954 |
L3 SMI联合APACHE Ⅱ评分比L3 SMI | 0.081 | 3.634 | <0.001 |
L3 SMI联合APACHE Ⅱ评分比APACHE Ⅱ评分 | 0.050 | 2.075 | 0.038 |
L3 SMI联合APACHE Ⅱ评分比SOFA评分 | 0.052 | 1.442 | 0.149 |
Table 4 Comparison of the predictive value of L3 SMI,SOFA score,APACHEⅡ score and combined variables on the risk of in-hospital mortality in older patients with intra-abdominal sepsis
指标 | 差异 | Z值 | P值 |
---|---|---|---|
SOFA评分比L3 SMI | 0.029 | 0.651 | 0.515 |
L3 SMI联合SOFA评分比L3 SMI | 0.084 | 3.587 | <0.001 |
L3 SMI联合SOFA评分比SOFA评分 | 0.054 | 2.114 | 0.035 |
L3 SMI联合SOFA评分比APACHE Ⅱ评分 | 0.052 | 1.577 | 0.115 |
L3 SMI联合SOFA评分比APACHE Ⅱ评分联合L3 SMI | 0.002 | 0.131 | 0.895 |
APACHE Ⅱ评分比L3 SMI | 0.031 | 0.722 | 0.470 |
APACHE Ⅱ评分比SOFA评分 | 0.002 | 0.058 | 0.954 |
L3 SMI联合APACHE Ⅱ评分比L3 SMI | 0.081 | 3.634 | <0.001 |
L3 SMI联合APACHE Ⅱ评分比APACHE Ⅱ评分 | 0.050 | 2.075 | 0.038 |
L3 SMI联合APACHE Ⅱ评分比SOFA评分 | 0.052 | 1.442 | 0.149 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
中华医学会外科学分会外科感染与重症医学学组,中国医师协会外科医师分会肠瘘外科医师专业委员会. 中国腹腔感染诊治指南(2019版)[J]. 中国实用外科杂志,2020,40(1):1-16. DOI:10.19538/j.cjps.issn1005-2208.2020.01.01.
|
[6] |
|
[7] |
|
[8] |
|
[9] |
中国急诊危重症患者肠内营养治疗专家共识组. 中国急诊危重症患者肠内营养治疗专家共识[J]. 中华急诊医学杂志,2022,31(3):281-290. DOI:10.3760/cma.j.issn.1671-0282.2022.03.004.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
汪颖,王迪芬,付江泉,等. SOFA、qSOFA评分和传统指标对脓毒症预后的判断价值[J]. 中华危重病急救医学,2017,29(8):700-704. DOI:10.3760/cma.j.issn.2095-4352.2017.08.006.
|
[21] |
|
[22] |
李平娜,杨宏富,崔秋敏,等. 脓毒症患者细胞因子表达水平及其对预后的影响[J]. 中华危重病急救医学,2023,35(12):1250-1254. DOI:10.3760/cma.j.cn121430-20230818-00660.
|
[23] |
|
[24] |
|
[25] |
|
[26] | |
[27] |
|
[28] |
|
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||